INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $122,000 | +17.3% | 77,900 | 0.0% | 0.00% | – |
Q2 2016 | $104,000 | -75.4% | 77,900 | -6.1% | 0.00% | -100.0% |
Q1 2016 | $423,000 | -20.8% | 83,000 | +22.1% | 0.00% | 0.0% |
Q4 2015 | $534,000 | -7.1% | 68,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $575,000 | -12.1% | 68,000 | +13.9% | 0.00% | -50.0% |
Q2 2015 | $654,000 | -12.1% | 59,700 | +12.2% | 0.00% | 0.0% |
Q1 2015 | $744,000 | -17.2% | 53,200 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $899,000 | +25.9% | 53,200 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $714,000 | +5.3% | 53,200 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $678,000 | +20.9% | 53,200 | +12.7% | 0.00% | +50.0% |
Q1 2014 | $561,000 | +7.3% | 47,200 | +24.5% | 0.00% | 0.0% |
Q4 2013 | $523,000 | +2.3% | 37,900 | +29.4% | 0.00% | 0.0% |
Q3 2013 | $511,000 | +1.4% | 29,300 | -5.5% | 0.00% | 0.0% |
Q2 2013 | $504,000 | – | 31,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |